Efter at have skiftet til 4, 6 mg/ 24 timer depotplastre, bør dosis på 4, 6 mg/ 24 timer, forudsat at denne er veltolereret efter minimum 4 ugers behandling, øges til 9, 5 mg/ 24 timer, som er den anbefalede effektive dosis.
After switching to 4.6 mg/ 24 h transdermal patches, provided these are well tolerated after a minimum of four weeks of treatment, the dose of 4.6 mg/ 24 h should be increased to 9.5 mg/ 24 h, which is the recommended effective dose.